SVRA
Savara IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.22B
P/E Ratio
—
EPS
$-0.53
Beta
0.31
52W High
$7.00
52W Low
$1.89
50-Day MA
$5.48
200-Day MA
$4.38
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
0.41
PEG Ratio
0.00
About Savara Inc
Savara Inc. is a lung disease orphan company. The company is headquartered in Austin, Texas.
Fundamentals
| Revenue (TTM) | 1,000 |
| Gross Profit (TTM) | $-81.40M |
| EBITDA | $-122.68M |
| Operating Margin | 0.00% |
| Return on Equity | -63.40% |
| Return on Assets | -32.90% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.80 |
| Price-to-Book | 5.59 |
| Price-to-Sales (TTM) | 145272.62 |
| EV/Revenue | 4269.22 |
| EV/EBITDA | -4.76 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $204.66M |
| Float | $130.01M |
| % Insiders | 2.33% |
| % Institutions | 97.59% |
Historical Volatility
HV 10-Day
49.17%
HV 20-Day
46.81%
HV 30-Day
49.42%
HV 60-Day
51.68%
HV Rank
15.9%
Volatility is currently contracting
Analyst Ratings
Consensus ($10.81 target)
2
Strong Buy6
BuyData last updated: 4/9/2026